Institute of Protein Biochemistry, Ulm University, 89081 Ulm, Germany.
Biochem Soc Trans. 2021 Apr 30;49(2):977-985. doi: 10.1042/BST20201022.
Systemic amyloidosis is defined as a protein misfolding disease in which the amyloid is not necessarily deposited within the same organ that produces the fibril precursor protein. There are different types of systemic amyloidosis, depending on the protein constructing the fibrils. This review will focus on recent advances made in the understanding of the structural basis of three major forms of systemic amyloidosis: systemic AA, AL and ATTR amyloidosis. The three diseases arise from the misfolding of serum amyloid A protein, immunoglobulin light chains or transthyretin. The presented advances in understanding were enabled by recent progress in the methodology available to study amyloid structures and protein misfolding, in particular concerning cryo-electron microscopy (cryo-EM) and nuclear magnetic resonance (NMR) spectroscopy. An important observation made with these techniques is that the structures of previously described in vitro formed amyloid fibrils did not correlate with the structures of amyloid fibrils extracted from diseased tissue, and that in vitro fibrils were typically more protease sensitive. It is thus possible that ex vivo fibrils were selected in vivo by their proteolytic stability.
系统性淀粉样变性定义为一种蛋白质错误折叠疾病,其中淀粉样并不一定沉积在产生原纤维前体蛋白的同一器官中。根据构成纤维的蛋白质不同,有不同类型的系统性淀粉样变性。这篇综述将重点介绍在理解三种主要类型的系统性淀粉样变性(系统性 AA、AL 和 ATTR 淀粉样变性)的结构基础方面取得的最新进展。这三种疾病是由血清淀粉样 A 蛋白、免疫球蛋白轻链或转甲状腺素蛋白错误折叠引起的。对淀粉样结构和蛋白质错误折叠研究方法的最新进展,特别是关于冷冻电子显微镜(cryo-EM)和核磁共振(NMR)光谱学的最新进展,使得对这些疾病的理解取得了重要进展。这些技术的一个重要观察结果是,以前描述的体外形成的淀粉样纤维的结构与从患病组织中提取的淀粉样纤维的结构不相关,并且体外纤维通常对蛋白酶更敏感。因此,体外纤维可能是由于其蛋白酶稳定性而在体内被选择的。